Injung Kim
Adult Health · Fairfax, VANPI 1487095311
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations.
Across 188 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$559
- Gilead$545
- Boehringer Ingelheim$431
- AstraZeneca$417
- Lilly USA, LLC$252
- Amgen$203
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,679100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 36 | $559 |
| Gilead | 21 | $545 |
| Boehringer Ingelheim | 19 | $431 |
| AstraZeneca(2 entities) | 19 | $417 |
| Lilly USA, LLC | 14 | $252 |
| Amgen | 12 | $203 |
| Amarin Pharma, Inc. | 8 | $175 |
| Pfizer | 7 | $165 |
| Johnson & Johnson | 7 | $136 |
| Esperion Therapeutics, Inc. | 7 | $122 |
| Astellas Pharma US Inc | 5 | $92 |
| Bayer | 5 | $79 |
| GSK | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| AbbVie | 2 | $43 |
| Dynavax Technologies Corporation | 2 | $38 |
| Exact Sciences | 2 | $38 |
| Dexcom, Inc. | 1 | $32 |
| Novartis | 2 | $30 |
| Sunovion Pharmaceuticals Inc. | 2 | $29 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Abbott | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Medtronic | 1 | $16 |
| VBI Vaccine (delaware) Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Metacel Pharmaceuticals LLC | 1 | $10 |
How this compares
$3,686 in reported general payments places this provider in the 85th percentile of 368 adult health providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProliaDenosumab | 55 | $94,444 |
| TradjentaLinagliptin | 19 | $30,041 |
| JanuviaSitagliptin Phosphate | 22 | $28,873 |
| JardianceEmpagliflozin | 14 | $18,021 |
| VemlidyTenofovir Alafenamide | 12 | $17,395 |
| VascepaIcosapent Ethyl | 19 | $11,042 |
| Lidocaine | 33 | $8,341 |
| Atorvastatin Calcium | 414 | $2,168 |
| Omega-3 Acid Ethyl Esters | 13 | $1,976 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,902 |
| FenofibrateFenofibrate Nanocrystallized | 52 | $1,332 |
| Rosuvastatin Calcium | 164 | $1,012 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 17 | $820 |
| Amlodipine Besylate | 243 | $665 |
| Pioglitazone Hcl | 65 | $601 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenProlia | $203 | $94,44455 claims |
| Boehringer IngelheimTradjenta, Jardiance | $431 | $48,06233 claims |
| GileadVemlidy | $545 | $17,39512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 368 adult health providers in Virginia.
Other adult health in Fairfax
- Theresa Harrington StukusFairfax$40K
- Courtney ChannelsFairfax$5K
- Christine KesslerFort Belvoir$107K
- Denise BruenCharlottesville$45K
- Chelsea KoskovichFredericksburg$34K
- Brittany BrownLynchburg$14K
- Colleen DieringVirginia Beach$13K
- Veronica HughesRichmond$12K
- Nicole SellersNorfolk$12K
- Amy WenzelMechanicsville$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.